RESUMEN
We developed and tested a smartphone-based intervention, FutureU, that aims to stimulate future-oriented thinking and behavior by strengthening the degree to which people identify with their future self. In order to examine the potential of this intervention prototype and opportunities for further optimization, we evaluated 1) the immediate and long-term efficacy of the intervention, and 2) intervention effects after each of three intervention modules. To this end, we conducted a randomized controlled pilot study among first-year university students (N = 176). Results showed a decrease in goal commitment immediately after the intervention. At 3-months follow-up, trends showed an increase in future orientation and in self-efficacy. During the intervention, there was a positive effect on vividness of the future self after the first module. Although there is scope for improvement, the findings highlight the potential of the intervention to increase people's future-oriented thinking and behavior.
Asunto(s)
Aplicaciones Móviles , Teléfono Inteligente , Humanos , Proyectos Piloto , AutoeficaciaRESUMEN
Pain disability is a primary target of treatment for chronic pain. Self-compassion shows promise as an intervention to reduce pain disability, but mechanisms linking self-compassion with less pain disability remain to be identified. This study examined two potential mechanisms, health self-efficacy and future self-identification (FSI), as parallel mediators of the relation between self-compassion and pain disability. Adults (N = 188; Mage = 40.34, SD = 11.53; 70.9% female) screened for chronic pain were recruited through online convenience sampling. Participants completed self-report measures of demographics, health status, and primary study variables. Self-compassion was positively associated with FSI and self-efficacy, but only self-efficacy was found to mediate the negative relation between self-compassion and pain disability, such that self-compassion was associated with higher self-efficacy, which was associated with less pain disability. Future experimental and longitudinal studies can establish whether the negative relation between self-compassion and pain disability is causal and mediated via health self-efficacy.
Asunto(s)
Dolor Crónico , Personas con Discapacidad , Humanos , Adulto , Femenino , Masculino , Autoeficacia , Autocompasión , Autoinforme , EmpatíaRESUMEN
BACKGROUND: Short-term mindsets are associated with self-defeating behaviors, such as delinquency and alcohol use. In contrast, people who consider the longer-term consequences of their decisions tend to report positive outcomes, like feeling more competent and enhanced goal achievement. We evaluate an intervention, FutureU, that aims to stimulate future-oriented thinking, increase goal achievement, and reduce self-defeating behavior, by strengthening people's identification with their future self. The intervention will be delivered through a smartphone application (app) or immersive Virtual Reality (VR). We test the effectiveness of FutureU for both delivery methods, examine working mechanisms, and identify potential moderators of intervention effects. METHODS: In this Randomized Controlled Trial, a total of 240 first-year university students (n = 80 per condition) will be randomized into one of three conditions: (1) a smartphone condition, (2) a VR condition, and (3) an active control condition. We will assess proximal (i.e., future self-identification) and distal intervention outcomes (e.g., future orientation, self-defeating behaviors, goal achievement), user engagement, and examine usage data and goal content. Assessments will take place at baseline, during the intervention, immediately after the intervention, and at 3- and 6-months follow-up. DISCUSSION: This study will provide information on the effectiveness of the intervention and allows for comparisons between delivery methods using novel technologies, a smartphone app versus immersive VR. Knowledge gained through this study can be used for further intervention development as well as theory building. Trial registration This trial is registered on Clinicaltrials.gov (NCT05578755) on 13 October 2022.